The inability of most drugs to cross the blood-brain barrier and/or plasma membrane limits their use for biomedical applications in the brain. Cell Permeable Peptides (CPPs) overcome this problem and are effective in vivo, crossing the plasma membrane and the blood-brain barrier. CPPs deliver a wide variety of compounds intracellularly in an active form. In fact, many bioactive cargoes have neuroprotective properties, and due to their ability to block protein-protein interactions, offer exciting perspectives in the clinical setting. In this review we give an overview of the Cell Permeable Peptides strategy to deliver neuroprotectants against neurodegeneration in the CNS. © 2010 by the authors.
CITATION STYLE
Antoniou, X., & Borsello, T. (2010). Cell permeable peptides: A promising tool to deliver neuroprotective agents in the brain. Pharmaceuticals. MDPI AG. https://doi.org/10.3390/ph3020379
Mendeley helps you to discover research relevant for your work.